Cytomx Therapeutics, Inc. (CTMX)

Last Three Months

31-Dec-22 -- 30-Mar-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

17

0

5

+1

0

+2

0

+3

Two Year Chart

31-Mar-21 -- 30-Mar-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Mar-23 6:43 PM View:	16-Mar-23 Sale ($4.03K)	Rowland Lloyd A General Counsel		Cytomx Therapeutics, Inc. - CTMX	48% 48.13K to 71.09K	0	0	--	--	Show Txns Hide Txns

20-Mar-23 6:43 PM View:	16-Mar-23 Sale ($8.42K)	Peterson Amy C. EVP, Chief Development Officer		Cytomx Therapeutics, Inc. - CTMX	(7%) 62.69K to 58.43K	0	0	--	--	Show Txns Hide Txns

20-Mar-23 6:43 PM View:	16-Mar-23 Sale ($3.46K)	Campoy Carlos Chief Financial Officer		Cytomx Therapeutics, Inc. - CTMX	(4%) 39.97K to 38.22K	0	0	--	--	Show Txns Hide Txns

20-Mar-23 6:43 PM View:	16-Mar-23 Sale ($1.02K)	Ogden Christopher SVP, Finance and Accounting		Cytomx Therapeutics, Inc. - CTMX	184% 13.29K to 37.77K	0	0	--	--	Show Txns Hide Txns

20-Mar-23 6:43 PM View:	16-Mar-23 Sale ($13.39K)	McCarthy Sean A. CEO Director		Cytomx Therapeutics, Inc. - CTMX	25% 384.1K to 481.98K	0	0	--	--	Show Txns Hide Txns

20-Mar-23 6:43 PM View:	16-Mar-23 Sale ($2.92K)	Landau Jeffrey B Chief Financial Officer		Cytomx Therapeutics, Inc. - CTMX	100% 38.41K to 76.93K	0	0	--	--	Show Txns Hide Txns

Yesterday 7:54 PM View:	22-Mar-23 Grant 0	Belvin Marcia SVP, Chief Scientific Officer		Cytomx Therapeutics, Inc. - CTMX	74% 80.82K to 140.82K	0	0	--	--	Show Txns Hide Txns